Open AccessOffer of methods for minimizing key investment risks of “R-Pharm” JSC
Author(s) -
N. Kabanova,
Irina Alekseeva
Publication year - 2020
Publication title -
problemy analiza riska
Language(s) - English
Resource type - Journals
eISSN - 2658-7882
pISSN - 1812-5220
DOI - 10.32686/1812-5220-2020-17-1-58-67
Subject(s) - investment (military) , business , risk analysis (engineering) , relevance (law) , key (lock) , order (exchange) , return on investment , financial risk , industrial organization , production (economics) , finance , computer science , economics , microeconomics , computer security , politics , political science , law
The article is devoted to the assessment of potential investment risks of the pharmaceutical company “R-Pharm” JSC with the aim of identifying the highest priority risks and developing methods for minimizing them. The relevance of the study is determined by the fact that the pharmaceutical business is characterized by a high degree of social orientation and annually invests $ 140 billion in the development of production and research, which determines the need for a risk-based approach to ensure the return on investment. The subject of this article is the investment risks of pharmaceutical companies, and the subject of research is the domestic pharmaceutical company “R-Pharm”. In order to assess the potential investment risks of “R-Pharm” JSC, the authors used elements of simulation modeling and system analysis. The proposed methods to minimize key investment risks are aimed at improving the efficiency of investment activities and is recommended as an element of the strategic planning of the company.